PE/Cyanine7 anti-human CD196 (CCR6) 353418 from BioLegend

Product Specs
ItemPE/Cyanine7 anti-human CD196 (CCR6)
CompanyBioLegend
Price Pricing Info Supplier Page View Company Product Page
Catalog Number353418
IsotypeIgG2b, Kappa
CloneG034E3
Quantity100 tests
HostMouse
Conjugate/TagPE_CYANINE7
ApplicationsFlow Cytometry (FC)
ReactivityHuman, Cynomolgus, Rhesus
NCBI Gene AliasesBN-1, C-C CKR-6, CC-CKR-6, CCR-6, CD196, CKR-L3, CKRL3, CMKBR6, DCR2, DRY6, GPR29, GPRCY4, STRL22
Antibody TypePrimary
NCBI Full Gene NameC-C motif chemokine receptor 6
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ImmunogenCCR6-transfected cells
ClonalityMonoclonal
TargetCD196

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Cytokine Storm Signature in Patients with Moderate and Severe COVID-19International Journal of Molecular SciencesAugust 10, 2022Olga Kalinina, Alexey Golovkin, Ekaterina Zaikova, Arthur Aquino, Vadim Bezrukikh, Olesya Melnik, Elena Vasilieva, Tatiana Karonova, Igor Kudryavtsev, Evgeny ShlyakhtoBioLegend, Inc., San Diego, CA, USA), PE/Cy7-labeled mouse anti-human CCR6 (CD196, clone G034E3, cat 353418, BioLegend, Inc., San Diego, CA, USA), APC-labeled mouse anti-human CXCR3 (CD183, clone G025H7, cat.

(2) Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19Pharmaceuticals (Basel)March 2, 2022Tatiana L. Karonova et al.BioLegend, Inc., San Diego, CA, USA); PE/Cy7-labeled mouse anti-human CCR6 (CD196, clone G034E3, cat 353418, BioLegend, Inc., San Diego, CA, USA); APC-labeled mouse anti-human CXCR3 (CD183, clone G025H7, cat.

(3) Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 ConvalescentsCurrent Issues in Molecular BiologyDecember 30, 2021Igor V. Kudryavtsev et al.assessed by using CXCR5-PerCP/Cy5.5 (CD185, cat. 356910, BioLegend, Inc., USA), CCR6-PE/Cy7 (CD196, cat 353418, BioLegend, Inc., USA), CXCR3-APC (CD183, cat. 353708, BioLegend, Inc., USA), and CCR4-BV510 CD194,

(4) Reduced mitochondrial respiration in T cells of patients with major depressive disorderiScienceNovember 19, 2021Gamradt S, Hasselmann H, Taenzer A, Brasanac J, Stiglbauer V, Sattler A, Sajitz-Hermstein M, Kierszniowska S, Ramien C, Nowacki J, et al.(G025H7),Biolegend,Cat# 353706; RRID: AB_10962912 PE/Cy7 anti-human CD196 (CCR6) (G034E3),Biolegend,Cat# 353418; RRID:AB_10916518 APC anti-human CD194 (CCR4) (L291H4),Biolegend,Cat# 359408; RRID:AB_2562429 Brilliant

(5) Transcriptomic effects of rs4845604, an IBD and allergy-associated RORC variant, in stimulated ex vivo CD4+ T cellsPLOS ONEOctober 21, 2021Paul A. Wilson et al.genotyped subjects. Cells were stained for CD4 PerCP-Cy5.5 (BD #560650), CCR6 (CD196) PeCy7 (BioLegend #353418), CXCR3 (CD183) FITC (R&D #FAB160F), CD45RA APC-H7 (BD #560674), and CD3 V450 (BD #560365) for 30 minutes

(6) Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19VirusesSeptember 30, 2021Alexey Golovkin, Olga Kalinina, Vadim Bezrukikh, Arthur Aquino, Ekaterina Zaikova, Tatyana Karonova, Olesya Melnik, Elena Vasilieva, Igor KudryavtsevBioLegend, Inc., San Diego, CA, USA), PE/Cy7-labelled mouse anti-human CCR6 (CD196, clone G034E3, cat 353418, BioLegend, Inc., San Diego, CA, USA), APC-labelled mouse anti-human CXCR3 (CD183, clone G025H7, cat.

(7) Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild diseaseImmunityJune 8, 2021Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, Ruffieux H, De Sa A, Huhn O, Morgan MD, et al.

(8) Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic DermatitisJID InnovMarch 1, 2021Imai Y, Kusakabe M, Nagai M, Yasuda K, Yamanishi K.#353705), anti-human CD4-PerCP/Cyanine5.5 (OKT4, #317427), anti-human CD196 (CCR6)-PE/Cyanine7 (G034E3, #353417), anti-human CD194 (CCR4)-APC (L291H4, #359407), and anti-human CD45-Brilliant Violet 510 (2D1, #368525)

(9) Human primed ILCPs support endothelial activation through NF-κB signalingeLifeFebruary 8, 2021Vanoni G, Ercolano G, Candiani S, Rutigliani M, Lanata M, Derré L, Marcenaro E, Schneider P, Romero P, Jandus C, et al.

(10) Reduced CD4+T Cell CXCR3 Expression in Patients With Allergic RhinitisFrontiers in ImmunologyNovember 3, 2020Xiaofeng Yu, Meng Wang, Zhiwei Caono. 359404), CXCR3-PE (Biolegend, USA, catalog no. 353706), CCR6-PE-Cy7 (Biolegend, USA, catalog no. 353418), CD25-BV421 (Biolegend, USA, catalog no. 302630), CD127-FITC (Biolegend, USA, catalog no. 351312),

(11) Increased Regulatory T Cells Precede the Development of Bronchopulmonary Dysplasia in Preterm InfantsFrontiers in immunologyJanuary 1, 2020Pagel J, Twisselmann N, Rausch TK, Waschina S, Hartz A, Steinbeis M, Olbertz J, Nagel K, Steinmetz A, Faust K, et al.

(12) A validated single-cell-based strategy to identify diagnostic and therapeutic targets in complex diseasesGenome medicineJuly 30, 2019Gawel DR, Serra-Musach J, Lilja S, Aagesen J, Arenas A, Asking B, Bengnér M, Björkander J, Biggs S, Ernerudh J, et al.CA, USA; cat. no. 353713), anti-human CD196 (CCR6)-PE/Cy7 (Biolegend, San Diego, CA, USA; cat. no. 353417), anti-human CD45RA-APC (Biolegend, San Diego, CA, USA; cat. no. 304111), anti-human CD25-APC/Cy7 (Biolegend,

(13) Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibodyCancer scienceOctober 1, 2018Yamaguchi K, Mishima K, Ohmura H, Hanamura F, Ito M, Nakano M, Tsuchihashi K, Ota SI, Wada N, Uchi H, et al.

(14) Deep analysis of immune response and metabolic signature in children with food protein induced enterocolitis to cow's milkClinical and translational allergyJanuary 1, 2018Adel-Patient K, Lezmi G, Castelli FA, Blanc S, Bernard H, Soulaines P, Dumond P, Ah-Leung S, Lageix F, de Boissieu D, et al.

(15) A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopeniaHaematologicaJune 1, 2016Flint SM, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, Newland AC, Savage CO, Henderson RB.eBioscience 45-0458), and anti-CXCR5 (PE, R&D Systems FAB190P) was supplemented with anti-CCR6 (PE-Cy7, BioLegend 353418), anti-PD1 (APC, BD Biosciences 558694), and anti-CXCR3 (FITC, R&D Systems FAB160F) for general T-cell subsets

(16) T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patientsThe Journal of clinical investigationAugust 3, 2015Boag SE, Das R, Shmeleva EV, Bagnall A, Egred M, Howard N, Bennaceur K, Zaman A, Keavney B, Spyridopoulos I.K036C2, #357212), CCR4 (clone L291H4, #359420), CCR5 (clone J418F1, #359108), CCR6 (clone G034E3, #353418), CXCR4 (clone 12G5, #306518), CXCR5 (clone J252D4, #356924), or CXCR6 (clone K041E5, #356012) (all

Write a Review

(1)

1/2/2024Fantastic Results Were Obtained With This PE/Cyanine7 Anti-Human CD196 (CCR6) Antibody Gemma FouldsThis antibody has been used to optimize flow cytometry-based immunophenotyping of PBMC samples. The results have not yet been published. Multi-colour antibody panels were designed to identify several ... Read Review
(1)

12/12/2018PE/Cy7 Anti-Human CD196 (CCR6) Antibody Gemma FouldsThis antibody has been used to optimise flow cytometry-based immunophenotyping of whole blood samples. The results have not yet been published. Multi-colour antibody panels were designed to identify a... Read Review

Frontiers in Immunology

Pharmaceuticals (Basel)

Pharmaceuticals (Basel)

Pharmaceuticals (Basel)

Frontiers in Immunology

PE/Cyanine7 anti-human CD196 (CCR6) from BioLegend

Description

BioLegend

Citations (16)

Reviews

PE/Cyanine7 anti-human CD196 (CCR6) from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map